{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T10:12:14Z","timestamp":1775470334432,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,29]]},"DOI":"10.7759\/cureus.44324","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T15:07:28Z","timestamp":1693321648000},"source":"Crossref","is-referenced-by-count":2,"title":["Dermatomyositis Flare-Up Following the SARS-CoV-2 Vaccine: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Robert","family":"Ryad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alsayed","family":"Osman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Almusa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Gerges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahar","family":"Sumbul-Yuksel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"COVID-19 Data Review. Update on COVID-19-Related Mortality. (2023). Accessed: June 6, 2023: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/science\/data-review\/index.html."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-022-08007-0","article-title":"The relationship of COVID-19 vaccination with mortality among 86,732 hospitalized patients: subpopulations, patient factors, and changes over time","volume":"38","author":"Baker TB","year":"2023","unstructured":"Baker TB, Bolt DM, Smith SS, et al.. The relationship of COVID-19 vaccination with mortality among 86,732 hospitalized patients: subpopulations, patient factors, and changes over time. J Gen Intern Med. 2023, 38:1248-55. 10.1007\/s11606-022-08007-0","journal-title":"J Gen Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2014.04.007","article-title":"Idiopathic inflammatory myopathies","volume":"32","author":"Dimachkie MM","year":"2014","unstructured":"Dimachkie MM, Barohn RJ, Amato AA. Idiopathic inflammatory myopathies. Neurol Clin. 2014, 32:595-628, vii. 10.1016\/j.ncl.2014.04.007","journal-title":"Neurol Clin"},{"key":"ref4","article-title":"Genetic and environmental risk factors for idiopathic inflammatory myopathies","volume":"28","author":"Reed AM","year":"2002","unstructured":"Reed AM, Ytterberg SR. Genetic and environmental risk factors for idiopathic inflammatory myopathies. Rheum Dis Clin North Am. 2002, 28:891-916.","journal-title":"Rheum Dis Clin North Am"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/0961203309345734","article-title":"Vaccines as a trigger for myopathies","volume":"18","author":"Orbach H","year":"2009","unstructured":"Orbach H, Tanay A. Vaccines as a trigger for myopathies. Lupus. 2009, 18:1213-6. 10.1177\/0961203309345734","journal-title":"Lupus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2010.07.003","article-title":"'ASIA' - autoimmune\/inflammatory syndrome induced by adjuvants","volume":"36","author":"Shoenfeld Y","year":"2011","unstructured":"Shoenfeld Y, Agmon-Levin N. 'ASIA' - autoimmune\/inflammatory syndrome induced by adjuvants. J Autoimmun. 2011, 36:4-8. 10.1016\/j.jaut.2010.07.003","journal-title":"J Autoimmun"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2013.08.005","article-title":"A review on the association between inflammatory myopathies and vaccination","volume":"13","author":"St\u00fcbgen JP","year":"2014","unstructured":"St\u00fcbgen JP. A review on the association between inflammatory myopathies and vaccination. Autoimmun Rev. 2014, 13:31-9. 10.1016\/j.autrev.2013.08.005","journal-title":"Autoimmun Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1126\/science.370.6520.1022","article-title":"Public needs to prep for vaccine side effects","volume":"370","author":"Wadman M","year":"2020","unstructured":"Wadman M. Public needs to prep for vaccine side effects. Science. 2020, 370:1022. 10.1126\/science.370.6520.1022","journal-title":"Science"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.13426","article-title":"Neurological complications of COVID- 19: Guillain- Barre syndrome following Pfizer COVID-19 vaccine","volume":"13","author":"Waheed S","year":"2021","unstructured":"Waheed S, Bayas A, Hindi F, Rizvi Z, Espinosa PS. Neurological complications of COVID- 19: Guillain- Barre syndrome following Pfizer COVID-19 vaccine. Cureus. 2021, 13:e13426. 10.7759\/cureus.13426","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11111106","article-title":"Myocarditis and pericarditis following COVID-19 vaccination: Inequalities in age and vaccine types","volume":"11","author":"Li M","year":"2021","unstructured":"Li M, Yuan J, Lv G, Brown J, Jiang X, Lu ZK.  Myocarditis and pericarditis following COVID-19 vaccination: Inequalities in age and vaccine types. J Pers Med. 2021, 11:1106. 10.3390\/jpm11111106","journal-title":"J Pers Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(21)00312-X","article-title":"Inflammatory myositis after ChAdOx1 vaccination","volume":"3","author":"Maramattom BV","year":"2021","unstructured":"Maramattom BV, Philips G, Thomas J, Santhamma SG. Inflammatory myositis after ChAdOx1 vaccination. Lancet Rheumatol. 2021, 3:e747-9. 10.1016\/S2665-9913(21)00312-X","journal-title":"Lancet Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcab043","article-title":"COVID-19 vaccine-related myositis","volume":"114","author":"Theodorou DJ","year":"2021","unstructured":"Theodorou DJ, Theodorou SJ, Axiotis A, Gianniki M, Tsifetaki N. COVID-19 vaccine-related myositis. QJM. 2021, 114:424-5. 10.1093\/qjmed\/hcab043","journal-title":"QJM"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcab161","article-title":"Myositis ossificans following COVID-19 vaccination","volume":"114","author":"Godoy IR","year":"2021","unstructured":"Godoy IR, Rodrigues TC, Skaf A. Myositis ossificans following COVID-19 vaccination. QJM. 2021, 114:659-60. 10.1093\/qjmed\/hcab161","journal-title":"QJM"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.88a.21038","article-title":"COVID-19 vaccine-induced cellulitis and myositis","volume":"88","author":"Ramalingam S","year":"2021","unstructured":"Ramalingam S, Arora H, Lewis S, Gunasekaran K, Muruganandam M, Nagaraju S, Padmanabhan P. COVID-19 vaccine-induced cellulitis and myositis. Cleve Clin J Med. 2021, 88:648-50. 10.3949\/ccjm.88a.21038","journal-title":"Cleve Clin J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2022.37.e32","article-title":"Dermatomyositis following BNT162b2 mRNA COVID-19 vaccination","volume":"37","author":"Gouda W","year":"2022","unstructured":"Gouda W, Albasri A, Alsaqabi F, Al Sabah HY, Alkandari M, Abdelnaby H. Dermatomyositis following BNT162b2 mRNA COVID-19 vaccination. J Korean Med Sci. 2022, 37:e32. 10.3346\/jkms.2022.37.e32","journal-title":"J Korean Med Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-022-03266-1","article-title":"Inflammatory myopathy occurring shortly after severe acute respiratory syndrome coronavirus 2 vaccination: two case reports","volume":"16","author":"Vutipongsatorn K","year":"2022","unstructured":"Vutipongsatorn K, Isaacs A, Farah Z. Inflammatory myopathy occurring shortly after severe acute respiratory syndrome coronavirus 2 vaccination: two case reports. J Med Case Rep. 2022, 16:57. 10.1186\/s13256-022-03266-1","journal-title":"J Med Case Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220231","article-title":"Safety of\u202fthe\u202ffirst\u202fdose of\u202fmRNA SARS-CoV-2\u202fvaccines in\u202fpatients with rheumatic and musculoskeletal diseases","volume":"80","author":"Connolly CM","year":"2021","unstructured":"Connolly CM, Ruddy JA, Boyarsky BJ, et al.. Safety of\u202fthe\u202ffirst\u202fdose of\u202fmRNA SARS-CoV-2\u202fvaccines in\u202fpatients with rheumatic and musculoskeletal diseases. Ann Rheum Dis. 2021, 80:1100-1. 10.1136\/annrheumdis-2021-220231","journal-title":"Ann Rheum Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/111114-dermatomyositis-flare-up-following-the-sars-cov-2-vaccine-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:56:13Z","timestamp":1707508573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/111114-dermatomyositis-flare-up-following-the-sars-cov-2-vaccine-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,29]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.44324","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,29]]}}}